C-type natriuretic peptide and vericiguat reduce proarrhythmic Ca2+ signals via PDE2 in heart failure

Research output: Contribution to journalConference articleContributedpeer-review

Details

Original languageEnglish
JournalClinical Research in Cardiology
Publication statusPublished - 11 Sept 2024
Peer-reviewedYes

Keywords